Vaginal oxytocin: an under- or overrated therapy for GSM?

J Sex Med. 2024 Feb 27;21(3):195-196. doi: 10.1093/jsxmed/qdad169.

Authors

Paul J Yong¹, Susan Kellogg Spadt², Megan L Falsetta³

Affiliations

¹ Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC, V6H3N1, Canada.
² Center for Pelvic Medicine, Bryn Mawr, PA, 19010, United States.
³ Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, 14620, United States.

PMID: 38427533
DOI: 10.1093/jsxmed/qdad169

No abstract available

Keywords: dyspareunia; genitourinary syndrome of menopause; menopause; oxytocin; vulvovaginal atrophy.

MeSH terms

Female
Humans
Menopause
Oxytocin* / therapeutic use
Vagina*

Substances

Oxytocin